Max Healthcare Institute Limited Share Price
Equities
MAXHEALTH
INE027H01010
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,004.65 INR | +1.22% |
|
-2.32% | -3.85% |
| 30/12 | Indian Equities End Marginally Lower on Tuesday Amid Cautious Trading | MT |
| 19/12 | Indian Equities Rebound on Friday as Rupee Stability Lifts Sentiment | MT |
| Capitalization | 97TCr 1.06TCr 904.36Cr 837.92Cr 788.06Cr 1.47TCr 1.57TCr 9.67TCr 3.82TCr 46TCr 3.98TCr 3.9TCr 1,67600Cr | P/E ratio 2026 * |
54.4x | P/E ratio 2027 * | 43.8x |
|---|---|---|---|---|---|
| Enterprise value | 99TCr 1.08TCr 923.13Cr 855.32Cr 804.42Cr 1.5TCr 1.61TCr 9.87TCr 3.9TCr 47TCr 4.06TCr 3.98TCr 1,71100Cr | EV / Sales 2026 * |
9.47x | EV / Sales 2027 * | 7.66x |
| Free-Float |
76.26% | Yield 2026 * |
0.19% | Yield 2027 * | 0.2% |
Last Transcript: Max Healthcare Institute Limited
| 15/22/15 | Max Healthcare Institute : ESOP/ESPS/SBEB Scheme | PU |
| 18/22/18 | Max Healthcare Institute : News Verification | PU |
| 10/22/10 | Max Healthcare Institute : Insider Trading - Others | PU |
| 04/22/04 | Max Healthcare Institute : Postal Ballot | PU |
| 1 day | +1.22% | ||
| 1 week | -2.32% | ||
| Current month | -3.85% | ||
| 1 month | -6.61% | ||
| 3 months | -16.92% | ||
| 6 months | -17.40% | ||
| Current year | -3.85% |
| 1 week | 977.65 |  | 1,039.8 |
| 1 month | 977.65 | | 1,095.8 |
| Current year | 977.65 | | 1,064 |
| 1 year | 940.35 | | 1,314.3 |
| 3 years | 412 | | 1,314.3 |
| 5 years | 158.9 | | 1,314.3 |
| 10 years | 64.95 | | 1,314.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Abhay Soi
CEO | Chief Executive Officer | 52 | 01/06/2020 |
| Director of Finance/CFO | 62 | 15/01/2012 | |
Dhiraj Aroraa
CMP | Compliance Officer | - | 03/02/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Abhay Soi
CHM | Chairman | 52 | 21/06/2019 |
Michael Neeb
BRD | Director/Board Member | 63 | 21/06/2019 |
| Director/Board Member | 69 | 21/06/2019 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.22% | -2.32% | -5.66% | +129.32% | 1.06TCr | |
| +0.21% | -3.24% | +45.49% | +75.63% | 11TCr | |
| +2.26% | +2.85% | +53.51% | -6.43% | 10TCr | |
| +1.21% | -8.95% | +30.71% | +68.13% | 3.11TCr | |
| +1.47% | +0.54% | -9.00% | +15.45% | 2.42TCr | |
| -0.86% | +2.95% | +10.55% | +4.62% | 2.25TCr | |
| -1.41% | -0.52% | +21.72% | +26.39% | 2.1TCr | |
| +0.17% | -1.49% | +43.03% | +273.36% | 1.7TCr | |
| +1.00% | +0.64% | +48.77% | +43.21% | 1.65TCr | |
| +1.28% | +1.19% | +6.79% | +35.83% | 1.25TCr | |
| Average | +0.67% | -0.02% | +24.59% | +66.55% | 3.63TCr | |
| Weighted average by Cap. | +0.90% | -1.13% | +36.51% | +48.72% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10TCr 114.33Cr 97Cr 90Cr 85Cr 158.06Cr 169.54Cr 1.04TCr 411.73Cr 4.95TCr 428.74Cr 419.95Cr 18TCr | 13TCr 140.48Cr 119.73Cr 110.94Cr 104.34Cr 194.21Cr 208.32Cr 1.28TCr 505.91Cr 6.08TCr 526.81Cr 516.01Cr 22TCr |
| Net income | 1.8TCr 20Cr 17Cr 16Cr 15Cr 27Cr 29Cr 180.25Cr 71Cr 855.76Cr 74Cr 73Cr 3.12TCr | 2.21TCr 24Cr 21Cr 19Cr 18Cr 33Cr 36Cr 220.86Cr 87Cr 1.05TCr 91Cr 89Cr 3.83TCr |
| Net Debt | 2TCr 22Cr 19Cr 17Cr 16Cr 30Cr 33Cr 200.75Cr 79Cr 953.08Cr 83Cr 81Cr 3.48TCr | 1.36TCr 15Cr 13Cr 12Cr 11Cr 21Cr 22Cr 136.4Cr 54Cr 647.59Cr 56Cr 55Cr 2.36TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/26/21 | 1,004.65 ₹ | +1.22% | 29,475 |
| 20/26/20 | 992.50 ₹ | -2.01% | 19,803 |
| 19/26/19 | 1,012.85 ₹ | -2.29% | 19,623 |
| 16/26/16 | 1,036.55 ₹ | +0.36% | 72,881 |
| 14/26/14 | 1,032.80 ₹ | +0.42% | 1,00,434 |
Delayed Quote Bombay S.E., January 21, 2026 at 03:57 pm IST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- MAXHEALTH Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition